Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Red Oak Partners, LLC MSGM Motorsport Games Inc. 13G/A 10.6% 5mo
EMINENCE CAPITAL, LP CWH Camping World Holdings, Inc. 13G/A 0% 5mo
Pacific Investment Management Company LLC RAIL FreightCar America, Inc. 13D/A 48.8% 5mo
Hudson Bay Capital Management LP PGAC PANTAGES CAPITAL ACQUISITION Corp 13G 13.27% 5mo
UCAM Limited GMTL Guardian Metal Resources PLC 13G/A 22% 5mo
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 0.69% 5mo
Alaris Master Fund LP PSBD Palmer Square Capital BDC Inc. 13G/A 4.9% 5mo
JENNISON ASSOCIATES LLC INN Summit Hotel Properties, Inc. 13G/A 10.8% 5mo
Brookstone Capital Management BAPR Sageworth Trust Co 13G/A 5.3% 5mo
JANE STREET GROUP, LLC HTZ Hertz Global Holdings, Inc 13G 5% 5mo
BlueCrest Capital Management Ltd AGLT Agility Robotics, Inc. 13G 5.6% 5mo
JANE STREET GROUP, LLC CXAI CXApp Inc. 13G 6.1% 5mo
JANE STREET GROUP, LLC SUNE SUNation Energy, Inc. 13G 5.1% 5mo
BIGGER CAPITAL FUND L P BTCT BTC Digital Ltd. 13G 5.6% 5mo
Hugreat Ltd. ALPX Alpex Acquisition Corp 13D 18% 5mo
MMCAP International Inc. SPC CGCF Cartesian Growth Corp IV 13G 8.5% 5mo
D. E. Shaw & Co., L.P. INSP Inspire Medical Systems, Inc. 13G 5.1% 5mo
Harraden Circle Investments, LLC ALPX Alpex Acquisition Corp 13G 5.45% 5mo
Bering Partners II GP, L.L.C. CALC CalciMedica, Inc. 13D 6.9% 5mo
Feis Equities LLC FWAC Futurewave Acquisition Corp 13G 7.81% 5mo
Rubenbauer Alois Ryan III ASBP Aspire-Lakewood Holdings, Inc. 13G 5% 5mo
Lynx1 Capital Management LP PASG Passage BIO, Inc. 13D 21% 5mo
Feis Equities LLC ALPX Alpex Acquisition Corp 13G 8.66% 5mo
D. E. Shaw & Co., L.P. AGIO Agios Pharmaceuticals, Inc. 13G 5.1% 5mo
WOLVERINE ASSET MANAGEMENT LLC CUB Lionheart Holdings 13G/A 0% 5mo
Castillo Christopher ADTX Aditxt, Inc. 13G/A 6.2% 5mo
NEEDHAM INVESTMENT MANAGEMENT LLC LTRX Lantronix Inc 13G 7.1% 5mo
Slow Ventures, LLC TMS Teamshares Inc 13G 6.9% 5mo
WOLVERINE ASSET MANAGEMENT LLC MACI Melar Acquisition Corp. I 13G/A 0% 5mo
Castillo Christopher ADTX Aditxt, Inc. 13G 9.19% 5mo
Lazar David E. KALA KALA BIO, Inc. 13D/A 3.9% 5mo
AyurMaya Capital Management Company, LP ALMS Alumis Inc. 13D/A 12.3% 5mo
New York Life Investment Management LLC BUYZ Franklin Templeton ETF Trust 13G/A 11.6% 5mo
Daqing Cai ALMR Alamar Biosciences, Inc. 13G 7.2% 5mo
Ningbo Pangu Chuangfu Hefu Equity Investment Partnership (Limited Partnership) ZBAO Zhibao Technology Inc. 13G 10.5% 5mo
Ian McDonald DRUG Bright Minds Biosciences Inc. 13D/A 13.7% 5mo
BARD ASSOCIATES INC PMNT Perfect Moment Ltd. 13G/A 0% 5mo
Fairmount Funds Management LLC ORKA Oruka Therapeutics, Inc. 13D/A 19.47% 5mo
Robert A. Ortenzio SEM Select Medical Holdings Corp 13D/A 0% 5mo
BORETA RONALD S AASP Agassi Sports Entertainment Corp. 13D/A 19.2% 5mo
Forsakringsaktiebolaget Avanza Pension HYPD Hyperion Defi, Inc. 13G/A 8.58% 5mo
Marathon Bank 401(k) Plan Trust MBBC Marathon Bancorp, Inc. 13G/A 7.32% 5mo
Skylark Partners I, LP ASTC ASTROTECH Corp 13G/A 0% 5mo
Chutzpah Holdings Limited PLUR Pluri Inc. 13D/A 18.5% 5mo
ResMed Inc. NYXH Nyxoah SA 13G/A 1.95% 5mo
Rosenberg J. David EWSB EWSB Bancorp, Inc. 13D 5.7% 5mo
Kamal Seyed Ghaffarian LUNR Intuitive Machines, Inc. 13D/A 19.7% 5mo
D. E. Shaw & Co., L.P. GOSS Gossamer Bio, Inc. 13D/A 8.3% 5mo
Phillip Frost, M.D. OPK Opko Health, Inc. 13D/A 34.1% 5mo
Corre Partners Management, LLC NNBR Nn Inc 13D/A 4% 5mo